| Date | Title | Description |
| 30.07.2025 | Automation Revolutionizes Hematology: Scopio Labs Leads With AI Diagnostics | Scopio Labs transforms hematology. The company secured a $10 million Series D extension, raising total funding to $52 million. This capital drives their new Complete Blood Morphology (CBM) analyzer. The CBM system leverages advanced AI and ... |
| 29.07.2025 | Scopio Labs: $10 Million More Raised For Automating Blood Morphology | Scopio Labs has launched its new AI-based Complete Blood Morphology (CBM) analyzer, designed to automate the traditionally manual blood morphology diagnostic process fully. This innovation seeks to address the global laboratory staffing cri... |
| 25.07.2025 | Scopio Labs Raises $10M in Series D Extension Funding | Scopio Labs, a Parsippany, NJ-based developer of Full-Field Cell Morphology imaging and analysis platform, raised $10M in Series D extension funding.
The round was led by Viola Growth, bringing the total to $52M.
The company intends to use ... |
| 28.07.2024 | The Resurgence of Private Equity and Health Tech Investments | The world of finance is like a tide. It ebbs and flows, sometimes revealing treasures, sometimes hiding them. Recently, the tide has turned, bringing a wave of activity in private equity and health technology investments. The recent acquisi... |
| 28.07.2024 | The Race for Healthcare Investment: A New Era in Medical Capital | The healthcare landscape is shifting. Private equity firms are circling like hawks, eyeing lucrative investments in medical institutions. The Asian Institute of Medical Sciences (AIMS) in Faridabad is the latest prize. With a valuation of ₹... |
| 26.07.2024 | Imperative Care closes potential $150M Series E and more digital health fundings | Photo: Anchiy/Getty Images
Medical technology company Imperative Care announced it initially closed an oversubscribed Series E financing round led by Ally Bridge Group. The company says additional closings of the round could bring its Serie... |
| 25.07.2024 | Scopio Labs Raises $42M in Funding | Scopio Labs, a Tel Aviv, Israel-based developer of full-field digital cell morphology imaging and analysis platforms, raised $42M in funding.
The round, which brought the total amount to $130M, was led by Fortissimo Capital, with participat... |
| 20.05.2024 | Scopio Labs Receives Groundbreaking FDA Clearance for First-Ever Digital Bone Marrow Aspirate Application | Scopio announced that it has been granted De Novo clearance by the U.S. Food and Drug Administration (FDA) for its Full-Field Bone Marrow Aspirate™ (FF-BMA) Applicationn |
| 04.03.2024 | Contributed: Nine revolutionary ways AI is advancing healthcare | Scopio Labs is the developer of full-field cell morphology - an AI-driven imaging platform that scans and shares in real time blood samples at high resolution. |
| 04.03.2024 | The Digital Age Of America’s Healthcare System Requires A Silicon Valley Approach | The need for the U.S. to step up its innovation investment in the MedTech industry so more companies like Scopio Labs have the ability to contribute life-changing technologies to the industry. |
| 28.04.2022 | Scopio aims to turn hematology into remote work with $50M C round | Today, if a hematologist wanted to dive into the exact organization and structure of your blood cells, they’d probably need a microscope in a lab. Scopio argues that soon, a lot of that work could be done with nothing more than a laptop. |
| 11.04.2022 | Scopio aims to turn hematology into remote work with $50M C round | Today, if a hematologist wanted to dive into the exact organization and structure of your blood cells, they’d probably need a microscope in a lab. Scopio argues that soon, a lot of that work could be done with nothing more than a laptop. |
| 09.02.2022 | Scopio Secures $50M for AI-Powered Peripheral Blood Smear App | What You Should Know:
– Scopio Labs, provider of the world’s first full-field digital cell morphology solution, today announced a $50M investment for its end-to-end hardware and software platform for digitizing, quantifying and analyzing he... |
| 09.02.2022 | Scopio aims to turn hematology into remote work with $50M C round | Today, if a hematologist wanted to dive into the exact organization and structure of your blood cells, they’d probably need a microscope in a lab. Scopio, an Israel-based startup that just closed a $50 million Series C round, argues that so... |
| 09.02.2022 | Scopio secures $50M in series C funding to develop telehematology imaging and AI analysis platform | The very common Peripheral Blood Smear review, used time and again for diagnostics, is typically conducted by a human analyzing the sample on a glass slide under a microscope and checking cell types, scouring for abnormalities that could in... |
| 09.02.2022 | Scopio raises $50M to take a deeper look into our blood cells | TEL AVIV, Israel, Feb. 9, 2022 /PRNewswire/ -- Scopio Labs, provider of the world's first full-field digital cell morphology solution, today announced a $50M investment for its end-to-end hardware and software platform for digitizing, quant... |
| 21.03.2021 | Scopio Labs Raises $16M in Series B Funding | Scopio Labs, a Tel Aviv, Israel-based advanced digital microscopy company, completed a $16m Series B funding round. The round was led by Olive Tree Ventures with participation from Aurum Ventures, OurCrowd, LR group and others. |
| 03.12.2020 | OTV Closes $170M Venture Fund | OTV, Israel's 'digital health first' venture capital firm, today announced the closing of a fund with a total value of $170M. OTV also announced their new name and the appointment of a new Head of Asia Pacific to spearhead the fund's expans... |
| 03.12.2020 | Israeli Digital Health VC Firm OTV Closes $170M Venture Fund | What You Should Know:
– OTV (formerly Olive Tree Ventures), Israel’s ‘digital health first’ venture capital firm closes $170 million venture fund to support innovative digital health companies worldwide.
– OTV also announced today a new Chi... |
| 03.12.2020 | OTV Closes $170M Venture Fund | OTV, Israel's 'digital health first' venture capital firm, today announced the closing of a fund with a total value of $170M. OTV also announced their new name and the appointment of a new Head of Asia Pacific to spearhead the fund's expans... |
| 21.10.2020 | Scopio Labs Receives FDA Clearance for its AI-Powered Full Field Peripheral Blood Smear (Full Field PBS) Application
USA - English
USA - English | |
| 28.04.2020 | Scopio Labs Raises $16M in Series B Funding | Scopio Labs, a Tel Aviv, Israel-based advanced digital microscopy company, completed a $16m Series B funding round.
The round was led by Olive Tree Ventures with participation from Aurum Ventures, OurCrowd, LR group and others.
The company,... |
| 13.02.2020 | Interested in Investing in Early Stage Firms? OurCrowd Has a Long List, Reports 36 Exits to Date | OurCrowd is arguably the leading investment crowdfunding platform in the world. Based in Israel but listing offerings from companies around the world, OurCrowd has seen approximately $1.4 billion in committed funding since inception. Of the... |
| 24.05.2017 | Scopio Labs Raises $7M in Funding | Scopio Labs, a Tel Aviv, Israel-based developer of an advanced digital microscopy and diagnostics platform, raised $7m in funding.
Equity crowdfunding platform OurCrowd will invest $2.5m in the round while other backers have not been disclo... |
| 24.05.2017 | Term Sheet — Wednesday, May 24 | ET CETERA
Purse purgatory: We’ve written about Coach’s increasing interest in M&A before. Today Fortune’s Phil Wahba published a feature on the company’s turnaround. The relevant part for Term Sheet readers:
Paid Content You can't secur... |
| 24.05.2017 | Israeli medtech startup Scopio Labs raises $7 million for expansion | Scopio Labs, a healthtech startup based in Tel Aviv, Israel, has raised $7 million in funding to expand its development. OurCrowd, an equity crowdfunding platform, contributed $2.5 million. The other backers have not been disclosed.
The com... |
| - | Scopio Labs | “With Scopio’s full-field imaging, lab teams, hematopathologists and clinicians can now get the complete picture for clinical decision-making.” |
| - | Стартап Scopio привлек $50 млн на разработку сканера для анализа мазка крови | Image credits: Scopio
19 19 комментариев
598 просмотров
Израильский мед-тех стартап Scopio занимается разработкой инструмента для удаленного анализа мазка крови. На прошлой неделе компания объявила о привлечении на проект 50 миллионов долла... |
| - | Scopio secures $50M in series C funding to develop telehematology imaging and AI analysis platform | The very common Peripheral Blood Smear review, used time and again for diagnostics, is typically conducted by a human analyzing the sample on a glass slide under a microscope and checking cell types, scouring for abnormalities that could in... |
